The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
Open accessAbstract
BACKGROUND: The incidence of hepatocellular carcinoma was reported to be increasing in the United States. However, alternate explanations were diagnostic or reclassification bias and changes in the demographic features of the general population. OBJECTIVE: To examine the temporal trends in the incidence of hepatocellular carcinoma. DESIGN: Retrospective cohort study. SETTING: Information collected by population-based registries of the Surveillance, Epidemiology, and End Results (SEER) program. PATIENTS: Persons given a diagnosis of hepatocellular carcinoma between 1975 and 1998. MEASUREMENTS: Linear Poisson multivariate regression model, controlling for differences in age, sex, race or ethnicity, and geographic region among patients with hepatocellular carcinoma and in the underlying population. RESULTS: The overall age-adjusted incidence rates of hepatocellular carcinoma increased from 1.4 per 100 000 in 1975 to 1977 to 3.0 per 100 000 in 1996 to 1998. There was a 25% increase during the last 3 years of the study compared with the preceding 3 years (1993 to 1995). The increase affected most age groups above 40 years, with the greatest increase in the 45- to 49-year-old age group. White men had the greatest increase (31%) in the last time period (1996 to 1998) compared with 1993 to 1995. The Poisson regression model confirmed an almost 2-fold increase in the incidence rate ratio for hepatocellular carcinoma between 1975 to 1978 and 1996 to 1998. CONCLUSIONS: The incidence of hepatocellular carcinoma continues to increase rapidly in the United States, with rates increasing the fastest in white men 45 to 54 years of age. These findings are consistent with a true increase and could be explained by consequences of hepatitis C virus acquired during the 1960s and 1970s.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Self-citationWarren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., & Riley, G. F. (2002) · PubMed · doi:10.1097/01.mlr.0000020942.47004.03 · Cited by 1,714
Alter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Colombo, M., Choo, Q. L., Del Ninno, E., Dioguardi, N., Kuo, G., Donato, M. F., Tommasini, M. A., & Houghton, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91016-7 · Cited by 666
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 523
Risk Factors for the Rising Rates of Primary Liver Cancer in the United States
El-Serag, H. B., & Mason, A. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3227 · Cited by 418
Self-citationExcess Risk of Primary Liver Cancer in Patients With Diabetes Mellitus
Adami, H.-O., Chow, W.-H., Nyren, O., Berne, C., Linet, M. S., Ekbom, A., Wolk, A., McLaughlin, J. K., & Fraumeni, J. F. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1472 · Cited by 373
Tanaka, Y., Hanada, K., Mizokami, M., Yeo, A. E. T., Shih, J. W.-K., Gojobori, T., & Alter, H. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242608099 · Cited by 331
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Self-citationPrimary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,477
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
Self-citationEvidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Bruix, J., Reig, M., & Sherman, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.041 · Cited by 1,694
Metadata
- Authors
- El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2003-11-18
- Volume
- 139
- Issue
- 10
- Pages
- 817-823
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2115754856
- Cited by
- 943
- References
- 18
- FWCI
- 32.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update. https://app.cochat.ai/papers/10.7326/0003-4819-139-10-200311180-00009
- The paper
- El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003). The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-139-10-200311180-00009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.